According to The Insight Partners market research study titled ‘Mobile Cardiac Telemetry Systems Market – Global Analysis and Forecasts by Technology and End User, the global Mobile cardiac telemetry systems market is expected to reach US$ 1,546.4 Mn in 2027 from US$ 564.8 Mn in 2018. The market is estimated to grow with a CAGR of 12.4% from 2019-2027. The report highlights the trends prevalent in the global mobile cardiac telemetry systems market and the factors driving the market along with those that act as deterrents to its growth.
Request for sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00003486/
The mobile cardiac telemetry systems market by technology is segmented into lead based and patch based systems. In 2018, the mobile cardiac telemetry systems with lead based segment held a largest market share of 60.1% of the mobile cardiac telemetry systems market, by technology. This segment is also expected to dominate the market in 2027 owing to advancements in ambulatory cardiac monitoring, and increasing rate of heart rhythm disorders. Moreover, the patch-based segment is anticipated to witness the fastest growth rate of 12.7% during the forecast period, 2019 to 2027 owing to advances in the technology of wearable cardiac monitors.
Key factors driving the market are, rising prevalence of cardiovascular diseases, benefits of monitoring patients with mobile cardiac telemetry (MCT), and rising geriatric population. However, factors such as stringent regulations for approval, and technical problems associated with the mobile cardiac telemetry (MCT) are likely to restrain the market growth to a certain extent.
Some of the prominent players operating in mobile cardiac telemetry systems market are, Medtronic, BioTelemetry Inc., Applied Cardiac Systems, Inc, Medicomp Inc, Preventice Services, LLC, The Scottcare Corporation, Medi-Lynx (Subisidiary Of Medicalgorithmics, S.A), Zoll Medical Corporation, Welch Allyn, and Telerhythmics, LLC. The market players are focused towards bringing new and innovative products and services to sustain their position in the market. For instance, in May 2018, Medtronic discontinued marketing for its SEEQ Mobile Cardiac Telemetry (MCT) System to concentrate support on its Reveal LINQ Insertable Cardiac Monitor (ICM) System.
Growing Applications of Mobile Cardiac Telemetry Systems in Healthcare to Drive Mobile Cardiac Telemetry Systems in Healthcare Market Growth
Cardiovascular diseases (CVDs) are the disorders of the heart and blood vessels and include cerebrovascular disease, coronary heart disease, rheumatic heart disease and other conditions. Some of the major factors which leads to the death and difficulties are use of tobacco, unhealthy diet, and physical inactivity which increases the risk of heart attacks and strokes. CVDs are the leading cause of death across the globe, it affects more people as compared to any other disease. According to the World Health Organization’s Fact sheet on cardiovascular diseases, in 2016, approximately 17.9 million people died from CVDs, which was 31.0% of all the global deaths. Among these approximately 85% were due to heart attack and stroke. Heart attacks and strokes are mainly caused due to fatty deposits that block the blood vessels that prevents blood from flowing to the heart or brain. Strokes are also caused due to bleeding from a blood vessel in the brain or from blood clots. Heart attacks and strokes are caused due to increased consumption of tobacco use, unhealthy diet and obesity, physical inactivity and rising alcohol consumption, hypertension, and diabetes.
According to the European Cardiovascular Disease Statistics 2017, in Europe, every year cardiovascular disease (CVD) causes 3.9 million deaths and more than 1.8 million deaths in the European Union (EU). The CVD accounts for 45.0% of all deaths in Europe and 37.0% of all deaths in the EU. CVD is the major reason of the death in men and women in all countries. Furthermore, as per the American Heart Association (AHA) 2019 statistics, 121.5 million adults in the U.S. which is around half of the US adult population, suffers from cardiovascular disease.
Owing to the rising cases of cardiovascular diseases across various countries, the need and demand for the mobile cardiac telemetry systems for the treatment of the CVD is expected to increase in the coming years.
The mobile cardiac telemetry (MCT) system is a small sensor and monitor that patients wear in their day to day life. Whenever cardiac events occur, MCT instantaneously transmits the data to a center for analysis and response, which in turn sends a report along with graphs and trends to the patient’s physician for diagnosis and therapy management. Use of MCT instead of an Event or a Holter monitor leads to better outcomes regarding diagnostic yield, management of arrhythmia through the use of antiarrhythmic drugs, and cost savings in the hospital for ablation, CABG, heart/pericardium, and valve/septa procedures. The MCT offers up to 30 days of retrievable ECG data, A-Fib onset and offset, episode, daily summary, and Urgent notifications, and full disclosure report on demand. It is an advanced algorithm that computes heart rate and detects asymptomatic and symptomatic arrhythmia at a wide variety of rates and durations.
MCT is one of the most effective methods of cardiac monitoring. The ability to analyze every heartbeat with little interference to the patient’s normal day, and the opportunity to initiate an immediate emergency response as needed, makes it one of the most attractive choices in today’s market. It delivers advantages to both the patient and the physician that can lead to more efficient care.
The rising population of the elderly people is the major cause of the heart diseases. The heart disease are mostly pone to the elderly people due to weak immunity and major other health problems. According to the United Nation’s World Population Ageing 2017 report, in 2017, there are 962 million people across the globe aged 60 years or over and the number is expected to reach nearly 2.1 billion by 2050.
Furthermore, US Census Bureau the number of Americans above the age of 65 and older is anticipated to grow more than double from 46 million in 2016 to above 98 million by 2060, and the 65-and-older age group’s share in the world’s population will grow around 24% from 15 percent.
In 2017, Europe has the largest percentage of population aging more than 60 or above (25%). The fast and rapid ageing is occurring in other parts of the world as well, so that by 2050 all regions of the world except Africa will have nearly a quarter or more of their populations at ages 60 and above. The number of older persons in the world is anticipated to be US$ 1.4 billion in 2030 and US$ 2.1 billion in 2050, and will rise above US$ 3.1 billion in 2100.
The elderly population are more prompt to have atypical presentations, comorbid conditions, and unfavorable outcomes. The major reason for the disease are related to the structural and functional changes in the cardiovascular system associated with the aging.
The rising geriatric population in the world leads to rise in cardiovascular disease which is likely to grow mobile cardiac telemetry solutions market in the coming years.
The report segments the global Mobile Cardiac Telemetry Systems Market as follows:
Global Mobile Cardiac Telemetry Systems Market – By Technology
Global Mobile Cardiac Telemetry Systems Market – By End User
Global Mobile Cardiac Telemetry Systems Market – By Geography
Purchase Copy of This Report at https://www.theinsightpartners.com/buy/TIPRE00003486/